We interpret the clinical and mechanistic data obtained for different agents that enable weight loss and glucose control for the treatment of obesity and type 2 diabetes mellitus, respectively, by activating or blocking GIPR signalling, including the GIPRGLP1R co-agonist tirzepatide, as well as the GIPR antagonistGLP1R agonist AMG-133
Intermediate Protocol After establishing tolerance, add weekly microneedling with a 0.25-0.5mm dermaroller
But reaching a sensible conclusion seems so much rarer in the face of a powerful trend that brings self-optimization to a toxic extreme
A study by Correa et al (2013) concludes that approximately 450ml per day paper-filtered coffee consumption (taken as 3 -4 cups per day with 15g beans of medium or medium-light roast prepared per 150ml cup over 4 weeks) makes no difference to total homocysteine, glycemic biomarkers or blood pressure in healthy participants but increases were observed for total cholesterol and other cardiovascular markers
As always, we at Peninsula Doctor team are here to answer any of your more specific questions about these medications and discuss whether GLP-1s may be a worthwhile option for you.
Multiple studies have investigated berberine's effect on GLP-1 secretion
